Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · IEX Real-Time Price · USD
3.160
-0.140 (-4.24%)
Jun 18, 2024, 4:00 PM EDT - Market closed

Tenaya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021
Market Capitalization
24822183782
Market Cap Growth
-165.36%-89.37%-
Enterprise Value
137128-88547
PE Ratio
-3.30-1.78-0.67-10.76
PB Ratio
1.571.580.342.81
P/FCF Ratio
-4.04-2.14-0.67-9.10
P/OCF Ratio
-4.09-2.16-0.80-12.86
EV/EBITDA Ratio
-2.66-1.140.77-7.96
EV/EBIT Ratio
-2.41-1.040.71-7.52
EV/FCF Ratio
-2.95-1.240.71-6.36
Debt / Equity Ratio
0.070.090.060.06
Debt / EBITDA Ratio
-0.10-0.11-0.13-0.23
Debt / FCF Ratio
-0.11-0.12-0.12-0.18
Quick Ratio
6.384.607.6911.54
Current Ratio
6.724.917.9911.73
Return on Equity (ROE)
-76.40%-69.90%-54.20%-76.60%
Return on Assets (ROA)
-64.80%-59.80%-47.40%-30.20%
Return on Capital (ROIC)
-77.40%-86.40%-48.60%-24.74%
Earnings Yield
-50.21%-56.23%-148.70%-9.30%
FCF Yield
-40.96%-46.81%-150.37%-10.98%
Buyback Yield / Dilution
-10.79%-64.61%-152.75%-1724.33%
Total Shareholder Return
-10.79%-64.61%-152.75%-1724.33%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).